Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Elemene, particularly β-elemene, targets multiple tumor cell signaling pathways simultaneously, including MAPK/ERK, PI3K/Akt/mTOR, NF-κB, JAK/STAT, and Wnt/β-catenin. This multi-targeted approach disrupts the complex network that allows cancer cells to survive, leading to induction of apoptosis, promotion of autophagy, cell cycle arrest, inhibition of multidrug resistance, and suppression of EMT, ultimately overcoming chemoresistance and exerting broad-spectrum antitumor effects.
Modulates gene/protein expression across pathways: induces apoptosis/autophagy/cell cycle arrest/inhibits MDR transporters
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple Tumor Cell Signaling Pathways.